The Board, inter-alia, considered and approved: A. The Un-Audited Standalone & Consolidated Financial Results of the Company for the Third Quarter & Nine Months ended on December 31, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Capital Ltd's Board, at its meeting on February 13, 2026, approved the unaudited standalone and consolidated financial results for Q3 FY26 (quarter ended Dec 31, 2025) and the nine-month period. On a consolidated basis, total income rose to ₹677.17 lacs in Q3 FY26 vs ₹535.94 lacs in Q3 FY25, with profit after tax at ₹356.16 lacs (up from ₹228.52 lacs YoY) and 9M PAT at ₹1,023.72 lacs (up ~76% from ₹580.28 lacs). Standalone results however showed zero revenue from operations and a loss of ₹17.31 lacs for the quarter and ₹49.01 lacs for the nine months. The Board also approved seeking shareholder approval via postal ballot for material related party transactions to be entered into during FY26-27, and appointed Ms. Ritu Mahajan as scrutinizer. Statutory auditor Mehrotra & Co issued an unmodified limited review report on both sets of results.
The strong consolidated earnings, driven largely by its subsidiaries (Health Care Energy Foods and others), paint a healthier picture than the standalone entity, which continues to post losses with no operating revenue and effectively nil other equity. The proposed material related party transactions for FY26-27 merit close shareholder scrutiny as they could involve value transfer between the listed entity and its subsidiaries.